Sector ratings Charles River Laboratories International, Inc. Deutsche Boerse AG

Stocks

Market Closed - Deutsche Boerse AG 11:31:48 02/10/2026 am IST			5-day change	1st Jan Change
254.80 ^EUR	-2.49%		-1.28%	+48.27%

30/09	UBS Upgrades Charles River Laboratories International to Buy From Neutral, Adjusts Price Target to $357 From $175	MT
29/09	PMGC Unit Working With Charles River Laboratories for Muscle Health Probiotic Testing	MT

Sector:

Location:

X axis:

Main competitors

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
WUXI APPTEC CO., LTD.	7.44TCr		AAA
ARGENX SE	5.93TCr		A
LONZA GROUP AG	4.71TCr		AAA
REVOLUTION MEDICINES, INC.	4.41TCr	-	B	-	-
IQVIA HOLDINGS INC.	4.29TCr		AAA
BEONE MEDICINES AG	4.08TCr		-
CELLTRION, INC.	3.08TCr		A
WUXI BIOLOGICS (CAYMAN) INC.	2.93TCr		AAA
BIONTECH SE	2.43TCr	-	-	-	-
INSMED INCORPORATED	2.37TCr	-	BBB	-	-
GENMAB A/S	2.08TCr		A
MEDPACE HOLDINGS, INC.	1.67TCr		BBB
PHARMAESSENTIA CORPORATION	1.52TCr		AA
ASCENDIS PHARMA A/S	1.49TCr	-	-	-	-
SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.	1.48TCr		AA
EUROFINS SCIENTIFIC SE	1.46TCr		AA
EXELIXIS, INC.	1.44TCr		BB
TEMPUS AI, INC.	1.38TCr		A		-
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	1.37TCr		AA
Average	2.92TCr		AA
Weighted average by Cap.			AA